Please download the dossier by clicking on the dossier button x
×

USE OF HE4 FOR ASSESSMENT OF BREAST CANCERS

  • US 20100311099A1
  • Filed: 03/31/2008
  • Published: 12/09/2010
  • Est. Priority Date: 03/29/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method of assessing whether a patient is afflicted with a breast cancer, the method comprising assessing expression of HE4 in a sample obtained from the patient, wherein elevated expression of HE4 is an indication that the patient is afflicted with breast cancer.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×